23.38
+0.07(+0.30%)
Currency In USD
| Previous Close | 23.31 |
| Open | 23.32 |
| Day High | 23.52 |
| Day Low | 22.93 |
| 52-Week High | 35.84 |
| 52-Week Low | 14.59 |
| Volume | 13,570 |
| Average Volume | 489,545 |
| Market Cap | 678.21M |
| PE | -68.76 |
| EPS | -0.34 |
| Moving Average 50 Days | 21.17 |
| Moving Average 200 Days | 21.48 |
| Change | 0.07 |
If you invested $1000 in Castle Biosciences, Inc. (CSTL) since IPO date, it would be worth $1,092.52 as of October 07, 2025 at a share price of $23.38. Whereas If you bought $1000 worth of Castle Biosciences, Inc. (CSTL) shares 5 years ago, it would be worth $433.36 as of October 07, 2025 at a share price of $23.38.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine
GlobeNewswire Inc.
Oct 01, 2025 8:30 PM GMT
Maetzold recognized among 586 applicants to The CEO Magazine’s 2025 Executive of the Year Awards — United States program FRIENDSWOOD, Texas, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health throu
Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award
GlobeNewswire Inc.
Sep 23, 2025 11:00 AM GMT
FRIENDSWOOD, Texas, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has been recognized as a Greater Pittsburgh Top Wor
Castle Biosciences Named One of Newsweek’s America’s Greatest Companies 2025
GlobeNewswire Inc.
Sep 17, 2025 11:00 AM GMT
FRIENDSWOOD, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, has been included in the inaugural 2025 America’s Greatest Companies list,